197 related articles for article (PubMed ID: 2188920)
1. Onchocerciasis.
Taylor HR
Int Ophthalmol; 1990 May; 14(3):189-94. PubMed ID: 2188920
[TBL] [Abstract][Full Text] [Related]
2. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
3. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
Berger IB; Nnadozie J
J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
[TBL] [Abstract][Full Text] [Related]
4. Population biology of human onchocerciasis.
Basáñez MG; Boussinesq M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
[TBL] [Abstract][Full Text] [Related]
5. [Molecular approaches to the control of onchocerciasis in Mexico].
Rodríguez-Pérez MA
Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
[TBL] [Abstract][Full Text] [Related]
6. Onchocerciasis.
Malatt AE; Taylor HR
Infect Dis Clin North Am; 1992 Dec; 6(4):963-77. PubMed ID: 1460274
[TBL] [Abstract][Full Text] [Related]
7. Onchocercal eye disease and the impact of Mectizan treatment.
Abiose A
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
[TBL] [Abstract][Full Text] [Related]
8. [The use of ivermectin in the control of onchocerciasis].
Chippaux JP; Boussinesq M; Prod'hon J
Sante; 1995; 5(3):149-58. PubMed ID: 7640897
[TBL] [Abstract][Full Text] [Related]
9. Control of onchocerciasis--the next generation.
Hotez PJ
Lancet; 2007 Jun; 369(9578):1979-1980. PubMed ID: 17574078
[No Abstract] [Full Text] [Related]
10. Eye lesions, blindness and visual impairment in the Taraba river valley, Nigeria and their relation to onchocercal microfilariae in skin.
Akogun OB
Acta Trop; 1992 Jun; 51(2):143-9. PubMed ID: 1354932
[TBL] [Abstract][Full Text] [Related]
11. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
12. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
Dadzie KY; Remme J; De Sole G
Trans R Soc Trop Med Hyg; 1991; 85(2):267-71. PubMed ID: 1887490
[TBL] [Abstract][Full Text] [Related]
13. [Ocular onchocerciasis in Israel].
Oshry T; Lifshitz T; Wender A; Yassur Y
Harefuah; 1995 Jan; 128(2):80-2, 128, 127. PubMed ID: 7721179
[TBL] [Abstract][Full Text] [Related]
14. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela.
Wkly Epidemiol Rec; 2006 Jul; 81(30):293-6. PubMed ID: 16874924
[No Abstract] [Full Text] [Related]
15. [Onchocerciasis].
Enk CD; Gardlo K; Ruzicka T; BenEzra D
Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
[TBL] [Abstract][Full Text] [Related]
16. River blindness elimination in Columbia.
Burki T
Lancet Infect Dis; 2013 Nov; 13(11):922-3. PubMed ID: 24319775
[No Abstract] [Full Text] [Related]
17. 15 years of APOC--a lifetime of public health evidence.
Allotey P; Amazigo U; Adjei S; Seddoh A; Lusamba-Dikassa PS
Lancet; 2012 Oct; 380(9851):1361-3. PubMed ID: 23084441
[No Abstract] [Full Text] [Related]
18. Visual loss in an onchocerciasis endemic community in Sierra Leone.
Whitworth JA; Gilbert CE; Mabey DM; Morgan D; Foster A
Br J Ophthalmol; 1993 Jan; 77(1):30-2. PubMed ID: 8435395
[TBL] [Abstract][Full Text] [Related]
19. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
20. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
